Internal Medicine, Hematology & Oncology · Atlanta, GA
NPI
1922086784
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1100 Johnson Fy Rd NE Ste 600
Atlanta, GA, 30342
Phone (404) 256-4777
Groups this clinician bills Medicare through
Medicare paid, 2024
$32K
561 services
Medicare patients, 2024
318
Average age 74
Drug cost, 2024
$776K
1,507 prescriptions
Company payments, 2025
$735
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kristina E Bowen was code 99213 (office e&m - established), 271 times for 191 patients. In total Kristina E Bowen billed 561 services in 14 codes, and Medicare paid $32K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-08-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Facility | 271 | 191 | $43.54 | $12K |
| 99214 Office E&M - Established | Facility | 101 | 69 | $61.60 | $6,222 |
| 99213 Office E&M - Established | Office | 70 | 41 | $44.52 | $3,116 |
| 99214 Office E&M - Established | Office | 35 | 22 | $63.90 | $2,237 |
| 99205 Office E&M - New | Facility | 27 | 27 | $142.79 | $3,855 |
| 99204 Office E&M - New | Facility | 19 | 19 | $99.42 | $1,889 |
By year: 2022 $37K for 600 services; 2023 $34K for 582 services; 2024 $32K for 561 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kristina E Bowen prescribed most often to Medicare patients was Letrozole, with 426 prescriptions and refills. In total Kristina E Bowen wrote 1,507 Medicare prescriptions that cost $776K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 426 | 1,071 | 125 | $11K |
| Tamoxifen Citrate Generic | 330 | 927 | 111 | $9,148 |
| Anastrozole Generic | 239 | 590 | 63 | $4,790 |
| Citalopram Hbr Citalopram Hydrobromide | 55 | 129 | 15 | $285 |
| Exemestane Generic | 39 | 97 | 17 | $5,292 |
| Ibrance Palbociclib | 37 | 37 | Under 11 | $585K |
| Gabapentin Generic | 34 | 41 | 11 | $126 |
| Dexamethasone Generic | 33 | 34 | 12 | $763 |
| Alendronate Sodium Generic | 30 | 84 | 13 | $176 |
| Ondansetron Hcl Generic | 29 | 30 | 16 | $224 |
| Raloxifene Hcl Generic | 27 | 59 | Under 11 | $694 |
| Lorazepam Generic | 21 | 21 | Under 11 | $38.24 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 19 | 19 | Under 11 | $192 |
| Zolpidem Tartrate Generic | 15 | 23 | Under 11 | $56 |
| Prochlorperazine Maleate Generic | 15 | 15 | 12 | $108 |
Brand drugs: 70 claims; generic drugs: 1,437 claims; opioid claims: 30.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kristina E Bowen $735 ($735 in general payments such as food, travel and fees) from 10 companies. The largest payer was Gilead Sciences, Inc. with $460.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 2 | $460 |
| Daiichi Sankyo Inc. 4568.T | 3 | $64.33 |
| Stemline Therapeutics Inc. | 1 | $33.14 |
| Merck Sharp & Dohme LLC MRK | 1 | $32.48 |
| Puma Biotechnology, Inc. PBYI | 1 | $27.97 |
| Celgene Corporation BMY | 1 | $27.6 |
| Tempus AI, Inc TEM | 1 | $27.12 |
| Pfizer Inc. PFE | 1 | $21.5 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $20.11 |
| Sobi, Inc SOBI.ST | 1 | $20.05 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.